MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-14-0011532
Unihelix Biotech Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.49 Cr
▲ 24% YoY
Net profit · FY 2025
₹2.13 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹5.85 Lakh
EBITDA margin 3.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
6
As per MCA filings
Active GSTINs
1
GST registered
About Unihelix Biotech Private Limited
Data last updated:
Unihelix Biotech Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 09 May 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2014PTC201749. Its GSTIN is 19AABCU7084J1ZT (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Subir Kumar Mondal and Bhairab Banerjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 238 Prafulla Kanan (East) Block – Ac, Kolkata, West Bengal, India – 700101.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.49 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹2.13 Lakh (net margin 1.4%) and EBITDA of ₹5.85 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 8% over five years.
Court records list 3 cases involving the company, including 3 filed against it; 2 cases are pending.
Unihelix Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-14-0011532). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unihelixbiotech.com.
Company details
CIN U24100WB2014PTC201749
Registration Number 201749
Incorporation Date 09 May 2014
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-14-0011532
Recognitions & Rankings of Unihelix Biotech
Contact details
Unihelix Biotech Private Limited's registered office is in Kolkata, West Bengal. Its website is unihelixbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address238 Prafulla Kanan (East) Block – Ac, Kolkata, West Bengal, India – 700101
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Unihelix Biotech Private Limited, buy the company report.
Comprehensive company report
Unihelix Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Unihelix Biotech is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Unihelix Biotech Private Limited, buy the company report.
Financials of Unihelix Biotech Private Limited
FY 2025 filings availableUnihelix Biotech Private Limited reported revenue of ₹1.49 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹1.49 Cr ▲ 24%
Net profit · FY 2025
₹2.13 Lakh margin 1.4%
EBITDA · FY 2025
₹5.85 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 19%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 267%
3 years · compounded
▲ 7%
5 years · compounded
▲ 54%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 24% growth in the latest year. EBITDA rose 267% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.85 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.13 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unihelix Biotech Private Limited, buy the company report.
Board of directors of Unihelix Biotech Private Limited
Unihelix Biotech has 6 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subir Kumar Mondal | Director | 09 May 2014 | 12 Years 5 Months | Current |
| Bhairab Banerjee | Director | 09 May 2014 | 12 Years 5 Months | Current |
| Sandip Ghosh | Director | 09 May 2014 | 12 Years 5 Months | Current |
| Sankar Dhar Also directs: Mountainmist Holidays Private Limited | Director | 09 May 2014 | 12 Years 5 Months | Current |
| Indra Narayan Palit Also directs: Nextend Business Solutions Private Limited | Director | 10 Jun 2022 | 4 Years 4 Months | Current |
| Ranajit Konar | Director | 08 Jun 2016 | 10 Years 4 Months | Current |
Auditor
Unihelix Biotech Private Limited is audited by KUMAR ROYBARMAN PRASANTA & ASSOC for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMAR ROYBARMAN PRASANTA & ASSOC | FY 2022 | 330634E |
Shareholding
The shareholding of Unihelix Biotech Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unihelix Biotech Private Limited, buy the company report.
Legal cases
Unihelix Biotech Private Limited has 3 court cases on record: 3 filed against it. 2 cases are pending and 1 is disposed.
Total cases
3
Filed against the company
3
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Franco - Indian Remedies Pvt Ltd | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Franco - Indian Remedies Pvt Ltd | Pending |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Franco - Indian Remedies Pvt Ltd | Disposed |
To see the full case history of Unihelix Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unihelix Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unihelix Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCU7084J1ZT | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unihelix Biotech Private Limited, buy the company report.
Recent activity
Unihelix Biotech Private Limited has 6 board changes on record since 2014: 6 appointments. The latest: Indra Narayan Palit was appointed as Director on 10 Jun 2022.
AGM
Unihelix Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Unihelix Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Appointed
Indra Narayan Palit was appointed as Director.
Appointed
Ranajit Konar was appointed as Director.
Appointed
Bhairab Banerjee was appointed as Director.
Appointed
Sandip Ghosh was appointed as Director.
Appointed
Sankar Dhar was appointed as Director.
Appointed
Subir Kumar Mondal was appointed as Director.
Incorporation
09 May 2014
Unihelix Biotech Private Limited was registered on 09 May 2014 with Roc Kolkata I & aged 12 years 5 months as per MCA records.
Frequently asked questions
Unihelix Biotech is an active private limited company based in Kolkata, West Bengal, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 09 May 2014 (12+ years old) and is registered under CIN U24100WB2014PTC201749.
Unihelix Biotech has 6 current directors:
- Subir Kumar Mondal - Director
- Bhairab Banerjee - Director
- Sandip Ghosh - Director
- Sankar Dhar - Director
- Indra Narayan Palit - Director
- Ranajit Konar - Director
The latest financial statements of Unihelix Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Unihelix Biotech is 19AABCU7084J1ZT, registered in West Bengal.
The CIN (Corporate Identification Number) of Unihelix Biotech is U24100WB2014PTC201749. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unihelix Biotech has 3 court cases on record: 3 filed against it. 2 are pending.
Unihelix Biotech was incorporated on 09 May 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kolkata.
Indra Narayan Palit was appointed as Director on 10 Jun 2022. Ranajit Konar was appointed as Director on 08 Jun 2016. Bhairab Banerjee was appointed as Director on 09 May 2014. Unihelix Biotech has 6 board changes on record in total.
Yes, Unihelix Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-14-0011532).
Unihelix Biotech can be reached through the website unihelixbiotech.com. Its registered office is in Kolkata, West Bengal, India.